Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Characterization of subepithelial interstitial cells in normal and pathological human prostate.

Gevaert T, Lerut E, Joniau S, Franken J, Roskams T, De Ridder D.

Histopathology. 2014 Sep;65(3):418-28. doi: 10.1111/his.12402. Epub 2014 Apr 30.

PMID:
24571575
2.

Phenotypic characterization of human prostatic stromal cells in primary cultures derived from human tissue samples.

Gravina GL, Mancini A, Ranieri G, Di Pasquale B, Marampon F, Di Clemente L, Ricevuto E, Festuccia C.

Int J Oncol. 2013 Jun;42(6):2116-22. doi: 10.3892/ijo.2013.1892. Epub 2013 Apr 10.

PMID:
23589051
3.

Expression analysis of thrombospondin 2 in prostate cancer and benign prostatic hyperplasia.

Matos AR, Coutinho-Camillo CM, Thuler LC, Fonseca FP, Soares FA, Silva EA, Gimba ER.

Exp Mol Pathol. 2013 Jun;94(3):438-44. doi: 10.1016/j.yexmp.2013.02.002. Epub 2013 Mar 5.

PMID:
23470460
4.

Immunolocalization of the keratinocyte growth factor in benign and neoplastic human prostate and its relation to androgen receptor.

Planz B, Aretz HT, Wang Q, Tabatabaei S, Kirley SD, Lin CW, McDougal WS.

Prostate. 1999 Dec 1;41(4):233-42.

PMID:
10544296
5.

Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.

Royuela M, De Miguel MP, Bethencourt FR, Sanchez-Chapado M, Fraile B, Paniagua R.

Growth Factors. 1998;16(2):101-10.

PMID:
9932228
6.

Expression of c-kit and kit-ligand in benign and malignant prostatic tissues.

Simak R, Capodieci P, Cohen DW, Fair WR, Scher H, Melamed J, Drobnjak M, Heston WD, Stix U, Steiner G, Cordon-Cardo C.

Histol Histopathol. 2000 Apr;15(2):365-74.

PMID:
10809354
7.

[Expressions of endothelin-1 in benign prostatic hyperplasia and prostate cancer and their significance].

Zhou WQ, Sun YH, Yin HL, Zhang ZY, Ge JP, Cheng W, Ma HQ, Wei W, Zhou SG, Ma HH, Gao JP.

Zhonghua Nan Ke Xue. 2007 Aug;13(8):685-9. Chinese.

PMID:
17918704
8.

Cytoskeletal and cytocontractile protein composition of stromal tissue in normal, hyperplastic, and neoplastic human prostate. An immunocytochemical study with monoclonal antibodies.

Castellucci E, Prayer-Galetti T, Roelofs M, Pampinella F, Faggian L, Gardiman M, Pagano F, Sartore S.

Ann N Y Acad Sci. 1996 Apr 30;784:496-508.

PMID:
8651605
9.

Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues.

Zhao H, Ramos CF, Brooks JD, Peehl DM.

J Cell Physiol. 2007 Jan;210(1):111-21.

10.

Dysregulation of Dkk-3 expression in benign and malignant prostatic tissue.

Zenzmaier C, Untergasser G, Hermann M, Dirnhofer S, Sampson N, Berger P.

Prostate. 2008 Apr 1;68(5):540-7. doi: 10.1002/pros.20711.

PMID:
18247400
11.

Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.

Royuela M, Ricote M, Parsons MS, García-Tuñón I, Paniagua R, de Miguel MP.

J Pathol. 2004 Jan;202(1):41-9.

PMID:
14694520
12.

Stromal response to prostate cancer: nanotechnology-based detection of thioredoxin-interacting protein partners distinguishes prostate cancer associated stroma from that of benign prostatic hyperplasia.

Singer E, Linehan J, Babilonia G, Imam SA, Smith D, Loera S, Wilson T, Smith S.

PLoS One. 2013 Jun 6;8(6):e60562. doi: 10.1371/journal.pone.0060562. Print 2013.

13.

Changes in caveolae, caveolin, and polymerase 1 and transcript release factor (PTRF) expression in prostate cancer progression.

Gould ML, Williams G, Nicholson HD.

Prostate. 2010 Nov 1;70(15):1609-21. doi: 10.1002/pros.21195.

PMID:
20564315
14.

Elevated epithelial expression of interleukin-8 correlates with myofibroblast reactive stroma in benign prostatic hyperplasia.

Schauer IG, Ressler SJ, Tuxhorn JA, Dang TD, Rowley DR.

Urology. 2008 Jul;72(1):205-13. doi: 10.1016/j.urology.2007.11.083. Epub 2008 Mar 7.

15.

Differential growth rates in stromal cultures of human prostate derived from patients of varying ages.

Sensibar JA, Pruden SJ, Kasjanski RZ, Rademaker A, Lee C, Grayhack JT, Kozlowski JM.

Prostate. 1999 Feb 1;38(2):110-7.

PMID:
9973096
16.

Relationship between the prostatic tissue components and natural history of benign prostatic hyperplasia.

Matsuda T, Fujime M, Suda K.

Anal Quant Cytol Histol. 2006 Jun;28(3):121-4.

PMID:
16786720
17.
18.

Stromal insulin-like growth factor binding protein 3 (IGFBP3) is elevated in the diseased human prostate and promotes ex vivo fibroblast-to-myofibroblast differentiation.

Sampson N, Zenzmaier C, Heitz M, Hermann M, Plas E, Schäfer G, Klocker H, Berger P.

Endocrinology. 2013 Aug;154(8):2586-99. doi: 10.1210/en.2012-2259. Epub 2013 May 29.

PMID:
23720424
19.

Characteristics of normal stromal components and their correlation with cancer occurrence in human prostate.

Zhang Y, Nojima S, Nakayama H, Jin Y, Enza H.

Oncol Rep. 2003 Jan-Feb;10(1):207-11.

PMID:
12469170
20.

Expression of proton-coupled oligopeptide transporter (POTs) in prostate of mice and patients with benign prostatic hyperplasia (BPH) and prostate cancer (PCa).

Sun D, Tan F, Fang D, Wang Y, Zeng S, Jiang H.

Prostate. 2013 Feb 15;73(3):287-95. doi: 10.1002/pros.22568. Epub 2012 Aug 9.

PMID:
22887093

Supplemental Content

Support Center